Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Instytut Hematologii I Transfuzjologii
Sponsor

Instytut Hematologii I Transfuzjologii

Poland Ul Indiry Gandhi 14, 02-776 Warsaw, Poland

About the sponsor

The sponsor’s clinical research activity is centred on aggressive blood cancers, with attention to diffuse large B-cell lymphoma and high-grade B-cell lymphoma arising from mature B-cells at advanced stages of differentiation.

  • Diffuse large B-cell lymphoma
  • High-grade B-cell lymphoma
  • B-cell neoplasms

These studies reflect a focus on relapsed disease biology and treatment selection in aggressive lymphoma settings.

About Specializations

Instytut Hematologii I Transfuzjologii runs clinical trials in conditions such as Plasma cell myeloma, Diffuse large B-cell lymphoma, Diffuse large B-cell lymphoma recurrent, Diffuse large B-cell lymphoma stage IV, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Plasma cell myeloma

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Instytut Hematologii I Transfuzjologii

Diffuse large B-cell lymphoma+7

Not yet recruiting
Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Instytut Hematologii I Transfuzjologii

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.